当前位置：首页 > 文献互助 > 互助详情

Heterogeneous Chiral Covalent Organic Framework for the Enantioselective Epoxidation of Styrenes and Chromenes复制

用户GG7UMeyeDh-A 2天前 16 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2025-12-19 23:05:49 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1021/acs.langmuir.3c01163复制

文献链接: https://pubs.acs.org/doi/10.1021/acs.langmuir.3c01163复制

其他信息:

上一篇：RNA Interference Targeting Liver Angiopoietin-Like Protein 3 Protects from Nephrotic Syndrome in a Rat Model Via Amelioration of Pathologic Hypertriglyceridemia

下一篇：Harnessing the Engineered 2D Triazine-Based Metal-Anchored Covalent–Organic Framework as a Catalyst for Selective Conversion of CO2 into Value-Added Products at Atmospheric Pressure

互助时间线

2025-12-12 23:06:11 [完结求助]

楼主确认了生活如歌应助的文件是正确的, 求助状态变成 已完结

2025-12-12 23:05:49 [上传文件]

生活如歌上传了文件(pdf 5.39 MB), 求助状态变成 待确认

2025-12-12 23:05:34 [发起求助]

最新发布的求助

SAFE Act hinders US-China collaboration 1小时前
Recombinant expression and functional characterization of human collagen III fragments 3小时前
Dual-orientation of collagen fibers to guide cell alignment in 3D-printed constructs 3小时前
Ultrasound-promoted, catalyst-free, greener synthesis of pyrazoles in aqueous medium 3小时前
Bridging the information gap in organic chemical reactions 5小时前
Controlled growth of ordered monolayers of N-heterocyclic carbenes on silicon 5小时前
On-surface synthesis of ballbot-type N-heterocyclic carbene polymers 5小时前
N-Heterocyclic carbenes as tunable ligands for catalytic metal surfaces 5小时前
Controlled growth of ordered monolayers of N-heterocyclic carbenes on silicon 5小时前
Recent advances in the chemistry and applications of N-heterocyclic carbenes 5小时前
097 Phase 3 results from an innovative trial design of treating plaque psoriasis involving difficult-to-treat, high-impact sites with icotrokinra, a targeted oral peptide that selectively inhibits the IL-23–receptor 6小时前
202 Efficacy and Safety of Icotrokinra, a Novel Targeted Oral Peptide, in Adolescents With Moderate-to-Severe Plaque Psoriasis: Subgroup Analyses From the Phase 3 ICONIC-LEAD Study 6小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com